Concepedia

Rituximab in combination with CHOP or fludarabine in low-grade lymphoma

Myron S. Czuczman, Alexandra Fallon, Alice Mohr, Carleton C. Stewart, Zale P. Bernstein, Philip Mccarthy, Marion Skipper, Karen Brown, Kena C. Miller, D Wentling,

Seminars in Oncology · 2002 · 97 citations · 5 references

DOI

Concepts

References

5

Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy

M. S. Czuczman, A.J. Grillo-López, Christine A. White et al. · Journal of Clinical Oncology · 1999 · 856 citations

, , +15

Chimeric Anti-CD20 (IDEC-C2B8) Monoclonal Antibody Sensitizes a B Cell Lymphoma Cell Line to Cell Killing by Cytotoxic Drugs

Aïcha Demidem, Tammy Lam, Steve Alas et al. · Cancer Biotherapy and Radiopharmaceuticals · 1997 · 398 citations

, , +17

Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma.

A.J. Grillo-López, Christine A. White, C. Varns et al. · PubMed · 1999 · 294 citations

, , +14

Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.

P. Solal-Céligny, Pauline Brice, Nicole Brousse et al. · Journal of Clinical Oncology · 1996 · 146 citations

, , +17

Ex vivo manipulation of hematopoietic stem cells for transplantation: the potential role of amifostine.

Monica Balzarotti, S. Grisanti, K. Granzow et al. · PubMed · 1999 · 92 citations

, , +14